| Primary Device ID | 10190302009171 |
| NIH Device Record Key | a27fdfdd-579c-40f9-9ddf-8df5c5e77dda |
| Commercial Distribution Discontinuation | 2022-04-27 |
| Commercial Distribution Status | Not in Commercial Distribution |
| Brand Name | 1% Triton® X-100 |
| Version Model Number | HFH10 |
| Company DUNS | 080131636 |
| Company Name | LIFE TECHNOLOGIES CORPORATION |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | true |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | false |
| Device Combination Product | false |
| Single Use | false |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 10190302009171 [Primary] |
| NJT | IMMUNOHISTOCHEMISTRY REAGENTS AND KITS |
| Steralize Prior To Use | false |
| Device Is Sterile | false |
| Public Version Status | Update |
| Device Record Status | Published |
| Public Version Number | 4 |
| Public Version Date | 2022-05-23 |
| Device Publish Date | 2018-02-02 |
| 10190302005197 - Aim -V™ Medium | 2024-06-04 AIM V MED |
| 10190302012041 - Human CD99 FITC Conjugate | 2024-06-04 HU CD99 3B2/TA8 FITC MAB |
| 10190302012058 - Human CD99 R-PE Conjugate | 2024-06-04 HU CD99 3B2/TA8 PE MAB |
| 10190302012065 - Human CXCR4 (CD184) R-PE Conjugate | 2024-06-04 HU CXCR4 12G5 PE MAB |
| 10190302012164 - Anti-Human HLA-DR (Class II) FITC Conjugate | 2024-06-04 HU HLA-DR TU36 FITC MAB |
| 10190302012171 - Anti-Human HLA-DR (Class II) R-PE Conjugate | 2024-06-04 HU HLA-DR TU36 PE MAB |
| 10190302012188 - Anti-Human HLA-DR (Class II) APC Conjugate | 2024-06-04 HU HLA-DR TU36 APC MAB |
| 10190302012195 - Anti-Human HLA-DR (Class II) PE-Texas Red® Conjugate | 2024-06-04 HU HLA-DR TU36 PE-TX RED MAB |